Page 7 - Priority Review News Today

Positive topline results showed treatment response consistent with NefIgArd findings, regardless of whether participants had previously been treated with Nefecon or placebo.

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated...

The FDA has granted priority review to dostarlimab plus chemotherapy for all adult patients with primary advanced or recurrent endometrial cancer.

Today, the FDA approved a new treatment for female adults with uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.

Acadia Pharmaceuticals Inc. today announced that Health Canada has accepted its New Drug Submission for trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Health...

Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The

The FDA has accepted for Priority Review the New Drug Application for IB1001 for the treatment of Niemann-Pick disease type C.

·         With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths worldwide·        ...

With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden ...

WALTHAM - Syndax Pharmaceuticals , a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the presentation of positive data from the pivotal...